IDO1 and cancer: To this end, targeting of antigens expressed not solely by cancer cells but by also cancer stromal cells, e.g., IDO-1 [34] could lead to influx of immune cells which in turn secrete IFN-γ, enabling subsequent targeting also of the true target i.e. the HLA molecules expressed by cancer cells.